Total Payments
$1,377
2024 Payments
$37.73
Companies
12
Transactions
68
Medicare Patients
3,034
Medicare Billing
$366,406
Payment Breakdown by Category
Food & Beverage$911.37 (66.2%)
Education$273.28 (19.8%)
Travel$192.61 (14.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $911.37 | 62 | 66.2% |
| Education | $273.28 | 4 | 19.8% |
| Travel and Lodging | $192.61 | 2 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $572.71 | 25 | $0 (2022) |
| Teleflex LLC | $254.14 | 6 | $0 (2022) |
| UROVANT SCIENCES INC | $167.66 | 14 | $0 (2022) |
| Allergan, Inc. | $86.41 | 6 | $0 (2022) |
| AbbVie Inc. | $74.72 | 5 | $0 (2023) |
| Medtronic USA, Inc. | $64.62 | 3 | $0 (2017) |
| PFIZER INC. | $55.12 | 3 | $0 (2023) |
| COLOPLAST CORP | $37.65 | 2 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $20.70 | 1 | $0 (2021) |
| Medtronic, Inc. | $17.56 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.73 | 2 | COLOPLAST CORP ($20.17) |
| 2023 | $74.65 | 4 | AbbVie Inc. ($49.88) |
| 2022 | $374.12 | 19 | Astellas Pharma US Inc ($180.52) |
| 2021 | $369.96 | 14 | Teleflex LLC ($215.46) |
| 2020 | $25.73 | 2 | NeoTract Inc. ($13.09) |
| 2019 | $153.65 | 5 | Astellas Pharma US Inc ($139.02) |
| 2018 | $156.40 | 11 | Astellas Pharma US Inc ($123.20) |
| 2017 | $185.02 | 11 | Astellas Pharma US Inc ($85.03) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Continence Care | ||||||
| 05/30/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/11/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/24/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/10/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/08/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.35 | General |
| 12/08/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $79.35 | General |
| 11/21/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Urology | ||||||
| 11/10/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $14.74 | General |
| Category: Urology | ||||||
| 10/03/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $9.35 | General |
| Category: Urology | ||||||
| 09/15/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $8.60 | General |
| Category: Urology | ||||||
| 08/30/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/22/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: Urology | ||||||
| 08/11/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $10.09 | General |
| Category: Urology | ||||||
| 07/14/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $9.66 | General |
| Category: Urology | ||||||
| 06/23/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $9.54 | General |
| Category: Urology | ||||||
| 05/18/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $12.63 | General |
| Category: Urology | ||||||
| 05/05/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Interventional Urology | ||||||
| 04/21/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $11.80 | General |
| Category: Urology | ||||||
| 03/24/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Interventional Urology | ||||||
| 03/14/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/10/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: Urology | ||||||
| 02/07/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Urology | ||||||
| 01/17/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 643 | 911 | $293,159 | $85,096 |
| 2022 | 19 | 716 | 943 | $312,073 | $83,249 |
| 2021 | 22 | 890 | 1,167 | $350,617 | $104,202 |
| 2020 | 19 | 785 | 1,018 | $331,869 | $93,860 |
Total Patients
3,034
Total Services
4,039
Medicare Billing
$366,406
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 20 | 198 | $125,214 | $26,373 | 21.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 80 | 104 | $35,830 | $12,625 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 109 | $26,718 | $9,156 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 119 | $20,587 | $7,040 | 34.2% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 14 | 16 | $17,614 | $6,750 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $17,545 | $6,309 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $11,800 | $4,124 | 35.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 18 | 22 | $8,739 | $3,082 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $8,118 | $2,797 | 34.5% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 28 | 28 | $7,214 | $2,553 | 35.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 34 | $3,614 | $1,243 | 34.4% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 48 | 54 | $2,252 | $1,021 | 45.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 20 | 46 | $2,794 | $994.80 | 35.6% |
| 50684 | Injection of ureter for imaging | Facility | 2023 | 36 | 41 | $4,899 | $965.97 | 19.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 16 | 19 | $221.00 | $59.09 | 26.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 19 | 165 | $140,250 | $22,249 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 119 | $28,153 | $10,560 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 72 | 83 | $27,347 | $10,459 | 38.2% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2022 | 16 | 17 | $18,819 | $7,079 | 37.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $17,023 | $5,881 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 108 | $17,858 | $5,797 | 32.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 24 | 31 | $11,842 | $4,941 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 49 | 49 | $10,207 | $3,377 | 33.1% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2022 | 33 | 33 | $8,580 | $2,624 | 30.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $6,392 | $2,098 | 32.8% |
About Dr. Patrick Stout, MD
Dr. Patrick Stout, MD is a Urology healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366415234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Stout, MD has received a total of $1,377 in payments from pharmaceutical and medical device companies, with $37.73 received in 2024. These payments were reported across 68 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($911.37).
As a Medicare-enrolled provider, Stout has provided services to 3,034 Medicare beneficiaries, totaling 4,039 services with total Medicare billing of $366,406. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Miami, OK
- Active Since 02/09/2006
- Last Updated 04/05/2017
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1366415234
Products in Payments
- UroLift System (Device) $215.46
- GEMTESA (Drug) $167.66
- XTANDI (Drug) $147.55
- BOTOX (Biological) $125.72
- Myrbetriq (Drug) $106.85
- MYRBETRIQ (Drug) $99.06
- INTERSTIM (Device) $82.18
- UROLIFT (Device) $38.68
- BOTOX THERAPEUTIC (Biological) $22.49
- ELIGARD (Drug) $20.70
- SpeediCath (Device) $20.17
- SPEEDICATH (Device) $17.48
- LYRICA (Drug) $15.72
- UroLift (Device) $13.09
- LUPRON DEPOT (Drug) $12.92
- XIAFLEX (Biological) $12.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Miami
Dr. Mark Anthony Gonzalgo, M.d, M.D
Urology — Payments: $1.0M
Urology $1.0M
Dr. Juan Suarez, M.d. , F.a.c.s, M.D. , F.A.C.S
Urology — Payments: $279,634
Urology $279,634
Dr. Bruce Kava, Md, MD
Urology — Payments: $164,319
Urology $164,319
Daniel Martinez, Md, MD
Urology — Payments: $153,910
Urology $153,910
Dr. Emad Ibrahim, M.d, M.D
Urology — Payments: $85,720
Urology $85,720
Sanoj Punnen
Urology — Payments: $48,269
Urology $48,269